Pendulum Probiotics for Gut Health, Metabolic Health, and Weight Management

For much of the supplement industry's history, probiotics were marketed as digestive products. They were something to take after antibiotics, during travel, or when bloating and bowel irregularity became a problem.

The microbiome has turned out to be considerably more interesting than that.

Intestinal bacteria participate in the metabolism of carbohydrates and fiber, production of short-chain fatty acids, transformation of bile acids, maintenance of the intestinal environment, immune signaling, and communication with cells that produce metabolic hormones. These processes do not make the microbiome the master switch for metabolism, but they place it squarely inside the larger metabolic system.

Pendulum has built its product line around this newer view of the gut.

Why Akkermansia Changed the Conversation

Akkermansia muciniphila lives close to the mucus layer lining the intestine. That puts it in a very different ecological position from many conventional probiotic organisms.

Over the past decade, researchers have repeatedly found associations between lower Akkermansia abundance and obesity, insulin resistance, type 2 diabetes, and other unfavorable metabolic patterns. An association is not proof that a missing bacterium caused the problem, but the findings were consistent enough to justify moving Akkermansia into controlled human studies.

That was an important step. Microbiome research is full of observations about bacteria that appear more or less abundant in different diseases. Far fewer organisms have progressed to actual human intervention trials.

An early randomized trial published in Nature Medicine in 2019 studied live and pasteurized Akkermansia in adults who were overweight or obese and had insulin resistance. The study was small, but metabolic changes were measurable, particularly with the pasteurized preparation.

The research has continued. A 2026 trial examining pasteurized Akkermansia after diet-induced weight loss found less weight regain during the maintenance period. Another 2026 metabolic-syndrome trial produced a more mixed overall result but suggested that baseline Akkermansia abundance may influence who responds.

That may eventually become one of the most useful lessons from this field. The value of a specific probiotic may depend not only on what is in the capsule, but on what is already living in the person taking it.

Akkermansia 500 PRO: The Focused Formula

Pendulum® Akkermansia 500 PRO is the most straightforward formula in the lineup. It provides 500 million AFU of live Akkermansia muciniphila with chicory inulin.

The logic is simple. Akkermansia is closely associated with the intestinal mucus layer, while inulin provides a fermentable prebiotic substrate that can support beneficial microbial activity.*

This is the Pendulum option that makes the most sense when live Akkermansia itself is the main reason for choosing the product rather than a broader multi-organism strategy.

Metabolic Daily: Five Organisms Working Together

Metabolic Daily takes a broader approach by combining five organisms:

• Akkermansia muciniphila
• Clostridium butyricum
• Clostridium beijerinckii
• Anaerobutyricum hallii
• Bifidobacterium infantis

The interesting part of the formula is not the number five. It is the relationship among those organisms.

Some participate in fermentation. Some contribute directly or indirectly to production of short-chain fatty acids. Some create metabolites that other organisms can use. Akkermansia occupies the mucus-associated environment. Together they represent a small microbial network rather than five unrelated probiotic ingredients.

Retail Metabolic Daily and Metabolic Daily PRO

There are two finished Metabolic Daily products, and the names make them easy to confuse.

The organisms are the same. The PRO formulation provides a little more than three times the labeled total AFU per capsule.

What we do not have is a head-to-head clinical trial showing that the higher organism count produces three times the benefit. Probiotic biology is not that linear. Strain behavior, dose, diet, substrate availability, gastrointestinal survival, baseline microbiome composition, and the surrounding intestinal environment all matter.

View Pendulum® Metabolic Daily

View Pendulum® Metabolic Daily PRO

For the full breakdown of the two formulas, see Pendulum® Metabolic Daily vs. Metabolic Daily PRO: Live Akkermansia, Butyrate & the 5-Strain Microbiome.

Why Butyrate Matters

Butyrate is one of the reasons the five-organism formula is more interesting than an ordinary probiotic blend.

It is a short-chain fatty acid produced through bacterial fermentation in the colon. Cells lining the colon use butyrate as an important energy source. It also participates in intestinal barrier physiology, immune signaling, and communication between the gut and metabolic systems.*

Several organisms in the Metabolic Daily ecosystem participate directly or indirectly in pathways that produce butyrate. This includes the process known as microbial cross-feeding, where the metabolic product of one bacterium becomes fuel for another.

Pendulum's earlier clinical research also offers some human evidence that this bacterial consortium can alter microbial metabolism. A follow-up analysis of its diabetes study found changes in circulating butyrate and in the bile acid ursodeoxycholic acid, or UDCA.

That is more interesting than simply showing that a swallowed bacterium later appeared in a stool sample. It suggests that changing the bacterial community can change what that community produces.

GLP-1 Probiotic PRO and the Gut's Own GLP-1 Signaling

Pendulum® GLP-1 Probiotic PRO is built around another rapidly developing area of microbiome research: the relationship between intestinal bacteria, microbial metabolites, and endogenous GLP-1.

GLP-1 is naturally released by enteroendocrine cells in the intestine. Food, bile acids, short-chain fatty acids, and other gut signals can influence that secretion. The microbiome therefore participates in the normal physiology surrounding GLP-1 production.

That is an interesting mechanism, particularly now that GLP-1 has become part of everyday language.

It is also quite different from the pharmacology of semaglutide or tirzepatide. Prescription GLP-1 and GIP/GLP-1 medications are designed to create prolonged receptor activity at pharmacologic exposure. Microbial signaling works through normal intestinal physiology and on a different scale.

We view GLP-1 Probiotic PRO as targeted microbiome support rather than a probiotic version of a GLP-1 medication.*

There is also not yet controlled evidence showing that adding this probiotic to semaglutide or tirzepatide reliably produces greater weight loss. It may still have a role in a broader gut-health strategy, but that is a different claim.

Glucose Control PRO Has the Strongest Clinical Lineage

Pendulum® Glucose Control PRO is the product in the Pendulum line with the closest relationship to the company's published randomized metabolic research.

A 2020 multicenter, double-blind, placebo-controlled trial enrolled 76 adults with type 2 diabetes. The five-organism research formulation, known as WBF-011, improved post-meal glucose exposure compared with placebo. An approximately 0.6 percentage point difference in A1C was also reported as a secondary outcome.

The trial was relatively small and should be viewed as proof-of-concept rather than a substitute for the much larger evidence base behind established diabetes treatment. Even so, it remains one of the more substantial human studies behind a commercial metabolic probiotic platform.

That research is also why Glucose Control should be distinguished from Metabolic Daily. The products share organisms, but the finished formulations, dosing strategies, and clinical evidence are not interchangeable.

Can Pendulum Probiotics Help With Weight Management?

The answer is more interesting than either “yes” or “no.”

The microbiome clearly participates in physiology relevant to body weight. It affects fermentation, bile acids, intestinal signaling, short-chain fatty acid production, glucose handling, immune communication, and the signals reaching enteroendocrine cells.

Human Akkermansia trials have also begun to produce weight-related findings, including the recent weight-maintenance study.

What has not been established is that a Pendulum probiotic by itself produces substantial, sustained weight loss in the way we would expect from an effective obesity treatment.

That is not really the standard by which we would judge it anyway.

Weight management is influenced by food intake, appetite biology, skeletal muscle, physical activity, sleep, visceral fat, hormones, medications, genetics, and environment. During medical weight loss, protein adequacy, resistance training, micronutrient intake, lean-mass preservation, and gastrointestinal tolerance all matter.

A targeted probiotic may fit into that larger plan. It does not need to carry the whole plan.

Choosing Among the Pendulum Formulas

There is enough overlap among these formulas that taking all of them is not automatically a better strategy. The useful question is why the probiotic is being used in the first place.

For a deeper product-by-product comparison, see Pendulum Probiotics Compared: Akkermansia, GLP-1, Metabolic Daily and Glucose Control.

Where This Fits in Longevity Medicine

The microbiome earns a place in longevity medicine because it interacts with systems we already care about: metabolic health, immune function, intestinal barrier physiology, nutrition, glucose regulation, appetite signaling, and inflammatory biology.

It should still remain in proportion.

A probiotic is not more important than exercise, muscle, adequate protein, fiber-rich food, sleep, blood pressure, lipid management, smoking avoidance, glucose control, or appropriate medication. Nor does a sophisticated bacterial strain compensate for a diet that provides very little substrate for a healthy microbial ecosystem.

This is why we tend to view microbiome supplements as tools rather than foundations. The foundation remains the environment in which the microbiome is living.

For the broader clinical framework, see Gut Health, Microbiome, and Longevity Medicine and Metabolic Health and Longevity Medicine.

Our View of Pendulum

Pendulum deserves attention because the company has done something more difficult than putting a new label on a conventional probiotic blend.

Live Akkermansia is technically challenging to manufacture. Several of the anaerobic organisms used in its metabolic formulas are not easy retail ingredients. The formulas reflect microbial cross-feeding and metabolite production rather than simply maximizing the number printed next to CFU or AFU. Pendulum has also taken part of its platform into randomized human research, which is still less common in the probiotic industry than the marketing would have you believe.

There are unanswered questions. We do not yet know how well baseline microbiome testing will predict response, whether higher probiotic potency consistently improves clinical outcomes, or which metabolic effects persist with long-term use.

That is normal for a field developing this quickly. The useful change is that the discussion has moved from “take a probiotic because probiotics are healthy” toward much more specific questions about organisms, functions, doses, metabolites, and clinical outcomes.

Pendulum is helping move the conversation in that direction.

Frequently Asked Questions

Are Pendulum probiotics designed for weight loss?

Pendulum's metabolic probiotics are built around organisms and microbial pathways relevant to metabolic physiology, but they should not be considered stand-alone weight-loss treatments. Their role is better understood as targeted microbiome support within a broader metabolic-health strategy.*

Can Pendulum probiotics be used with semaglutide or tirzepatide?

They may be considered as part of a broader gut-health strategy, but controlled trials have not established that adding a Pendulum probiotic increases the amount of weight lost with semaglutide or tirzepatide.

Does GLP-1 Probiotic PRO work like a GLP-1 medication?

No. Gut microbes and microbial metabolites can participate in the body's normal GLP-1 signaling, but this is different from the sustained pharmacologic receptor activity produced by medications such as semaglutide or tirzepatide.

What is Akkermansia muciniphila?

Akkermansia muciniphila is a naturally occurring intestinal organism that lives close to the mucus layer and has become an important subject of human research involving intestinal and metabolic physiology.

What is the difference between Metabolic Daily and Metabolic Daily PRO?

Both contain the same five organisms. Retail Metabolic Daily provides 300 million AFU per capsule and is available in 30- and 90-capsule sizes. Metabolic Daily PRO provides 1 billion AFU per capsule in a 30-capsule professional formulation.

Is Metabolic Daily PRO more effective because it contains more AFU?

That has not been established. Metabolic Daily PRO has a higher labeled organism count, but the retail and PRO formulations have not been compared head-to-head in a clinical outcomes trial.

Which Pendulum product has the strongest direct clinical evidence?

The Glucose Control platform has the closest relationship to Pendulum's published randomized human research involving post-meal glucose control in adults with type 2 diabetes.

What is butyrate?

Butyrate is a short-chain fatty acid produced through bacterial fermentation in the colon. Colon cells use it as an important energy source, and it participates in normal intestinal-barrier, immune, and metabolic signaling.*

Selected Research

• Perraudeau F, et al. Improvements to postprandial glucose control in subjects with type 2 diabetes: randomized placebo-controlled trial. BMJ Open Diabetes Research & Care. 2020.
• Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes.
• Depommier C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers. Nature Medicine. 2019.
• Mount S, et al. Pasteurized Akkermansia muciniphila for weight-loss maintenance in people with overweight and obesity. Nature Medicine. 2026.
• Pasteurized Akkermansia muciniphila, insulin sensitivity, GLP-1 production, and baseline microbiome status in metabolic syndrome. 2026.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.